Author Archives: Jason Carr
B.Riley FBR Sticks to Their Buy Rating for Colony Credit Real Estate Inc (CLNC)
In a report released today, Randy Binner from B.Riley FBR reiterated a Buy rating on Colony Credit Real Estate Inc (CLNC – Research Report), with a price target of $19. The company’s shares closed last Monday at $13.09, close to
Extended Stay America (STAY) Received its Third Buy in a Row
After Nomura and Robert W. Baird gave Extended Stay America (NASDAQ: STAY) a Buy rating last month, the company received another Buy, this time from Deutsche Bank. Analyst Chris Woronka reiterated a Buy rating on Extended Stay America yesterday and
Navigant Consulting (NCI) was Downgraded to a Hold Rating at Barrington
Navigant Consulting (NCI – Research Report) received a Hold rating from Barrington analyst Kevin Steinke today. The company’s shares closed last Monday at $27.81, close to its 52-week high of $28.21. According to TipRanks.com, Steinke is a 3-star analyst with
Brighthouse Financial Inc (BHF) Gets a Hold Rating from Morgan Stanley
In a report released today, Nigel Dally from Morgan Stanley maintained a Hold rating on Brighthouse Financial Inc (BHF – Research Report), with a price target of $41. The company’s shares closed last Monday at $35.04. According to TipRanks.com, Dally
Extendicare (EXE) Got Some Good News
Shares of Extendicare (EXE – Research Report) were revisited by a Wall Street analyst yesterday. The Services company, Extendicare (TSX: EXE) has just received a rating update from a Wall Street analyst. According to TipRanks.com, Loe is currently ranked with
Analysts Offer Insights on Healthcare Companies: Nabriva (NASDAQ: NBRV) and Sarepta Therapeutics (NASDAQ: SRPT)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Nabriva (NBRV – Research Report) and Sarepta Therapeutics (SRPT – Research Report) with bullish sentiments. Nabriva (NBRV) Northland Securities analyst Carl Byrnes
